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Background/Aims
Irritable bowel syndrome (IBS) is a widespread chronic health condition which is significantly more prevalent in women. We 
conducted a gender difference analysis by comparing findings of men and women to determine whether any significant differ-
ences exist or not.
Methods
This single-center study was conducted in Tehran, Iran during 2009-2010. IBS was diagnosed on the basis of Rome III criteria. 
A simple “10 point” objective questionnaire was used.
Results
A total number of 144 IBS patients including 44 (30.6%) males and 100 (69.4%) females with the mean age of 37.50 ± 
11.50 years, were assessed. The only differently observed symptom was nausea which was significantly more prevalent in fe-
males (49% vs 18.2%, P ＜  0.001). The commonest subtype of IBS in male patients was diarrhea predominant IBS (38.6%); 
while, constipation predominant IBS was the most frequent type among females (38%). Moreover, the frequency of loose, 
mushy or watery stools within the last 3 months was significantly higher among males (2.11 ± 1.67 vs 1.37 ± 1.50, P = 
0.009).
Conclusions
We report that gender is important in IBS. Although qualitative comparison of different subtypes of IBS between male and 
female failed to meet the statistically significant level, the answers to the corresponding questions of ROME III IBS module sug-
gest the higher prevalence of bowel movements and looser stool in males. Moreover, nausea was reported more often by 
females.
(J Neurogastroenterol Motil 2012;18:70-77)
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Introduction
Irritable bowel syndrome (IBS) is a widespread chronic 
health condition, characterized by a defined symptom complex in 
the absence of any biochemical or pathological structural 
abnormalities. The novelest symptom criteria are the Rome III 
criteria.
1 Accordingly, criterion fulfilled for the last 3 months 
with symptoms begun at least 6 months prior to diagnosis, would 
make IBS diagnosis complete. IBS is classified as diarrhea-pre-
dominant, constipation predominant, or alternating based on the 
predominant bowel habit.
2
In Asian countries, 1% to 10% of the population has symp-
toms compatible with IBS.
3 Despite the high prevalence of IBS, 
the etiology of this condition remains unknown. A long-recog-
nized characteristic of IBS is gender disparity, whereby female 
patients appear to outnumber male patients in a ratio of 2:1.
4 
While the underlying mechanism for this disparity is not well un-
derstood, the observation of gender differences in functional 
bowel disorders extends beyond IBS as well.
The concept of gender role will be suggested as a possible 
contributing factor in the prevalence of IBS for both women and 
men. In general, women are more likely to complain of persistent, 
episodic or chronic visceral and musculo-skeletal pains. Women 
do report more multiple or recurrent pains than men.
3-8
In examining the literature on gender differences in IBS, it is 
apparent that most of the research has not tested for these differ-
ences in a scientifically rigorous manner.
9,10 Some studies on IBS 
enrolled only women in their samples, although some others did 
include men, and there was often no gender difference in the anal-
ysis performed beyond description of sample demographics.
11-14
Moreover, most of the previous studies on gender-related 
differences in IBS symptoms were based on the previous versions 
of ROME criteria.
15-17 To our knowledge few studies to date 
have examined this association according to the ROME III 
criteria. In this study, we conducted a gender difference analysis 
by comparing findings for men and women through statistical 
analyses to determine whether or not significant differences 
existed.
Materials and Methods
Patient Enrollment
This single-center study was conducted in a private Gastro-
enterology Clinic in Tehran, Iran during 2009-2010. IBS was di-
agnosed on the basis of Rome III criteria, according to which, re-
current abdominal pain or discomfort at least 3 days per month in 
the last 3 months with onset of symptoms at least 6 months back 
was essential for suspecting IBS. In addition, to diagnose a per-
son as IBS, the pain was needed to be associated with at least 2 out 
of 3 features which included improvement of pain or discomfort 
with defecation and onset of pain or discomfort associated with 
changes in frequency or form (appearance) of stool. Imaging 
studies including colonoscopy were also performed wherever the 
approved criteria were met (eg, presence of diarrhea and age ＞ 50 
years). Furthermore, any cases with any organic disorders, in-
flammatory bowel disease, celiac disease, malabsorption disorders 
and gall bladder diseases were excluded from the study.
The study protocol was approved by the ethics committee of 
medical faculty, Tehran University of Medical Sciences (TUMS).
Assessments
Finally 144 patients were confirmed to have IBS and re-
cruited to the study. A simple “10 point” objective questionnaire 
based on Rome III IBS module
1 (Table 1) was used in this study. 
The English version of the official ROME III questionnaire was 
previously translated into the native language Persian. The val-
idity and reliability of this translated questionnaire were formerly 
evaluated in another study on Iranian IBS patients which were 
shown to be valid and reliable, showing a value of above 0.7 for 
Cronbach alpha coefficient.
18
Thereafter, the patients were further subclassified into diar-
rhea predominant IBS (IBS-D) if they had loose, mushy or water 
stools in the last 3 months with no hard or lumpy stools ([ques-
tion 9 = 0] and [question 10 ＞ 0]); constipation predominant 
IBS (IBS-C), if they had hard or lumpy stools with no loose, wa-
tery mushy or watery stools in the past 3 months ([question 9 ＞ 
0] and [question 10 = 0]); mixed IBS (IBS-M), if they had 
both loose and hard stools in the past 3 months ([question 9 ＞ 
0] and [question 10 ＞ 0]); and unsubtyped IBS (IBS-U), if 
they did not report either loose or hard stools in the past 3 months 
([question 9 = 0] and [question 10 = 0]).
In addition to the IBS modules, baseline characteristics of the 
patients including sex, age, marital status, educational level, occu-
pational category and history of smoking were recorded. More-
over, the data on their related symptoms consisted of reflux, nau-
sea, vomiting, anorexia, weight loss, fatigue and heart burn were 
asked and added to the medical records of the IBS patients. It 
must be noted that the description for these symptoms was based Sanam Javid Anbardan, et al
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Table 1. Irritable Bowel Syndrome Module According to ROME Criteria III (Modified from Longstreth et al
1)
Question Answer
  1. In the last 3 months, how often did you have discomfort or pain anywhere in your abdomen? 0 Never 
1 Less than one day a month
2 One day a month
3 Two to three days a month
4 One day a week
5 More than one day a week
6 Every day
  2. For women: Did this discomfort or pain occur only during your menstrual  0 No
bleeding and not at other times? 1 Yes
2 Does not apply because I have had the 
change in life (menopause) or I am a male
  3. Have you had this discomfort or pain 6 months or longer? 0 No
1 Yes
  4. How often did this discomfort or pain get better or stop after you had a bowel movement? 0 Never or rarely
1 Sometimes
2 Often
3 Most of the time
4 Always
  5. When this discomfort or pain started, did you have more frequent bowel movements? 0 Never or rarely
1 Sometimes
2 Often
3 Most of the time
4 Always
  6. When this discomfort or pain started, did you have less frequent bowel movements? 0 Never or rarely
1 Sometimes
2 Often
3 Most of the time
4 Always
  7. When this discomfort or pain started, were your stools (bowel movements) looser? 0 Never or rarely
1 Sometimes
2 Often
3 Most of the time
4 Always
  8. When this discomfort or pain started, how often did you have harder stools? 0 Never or rarely
1 Sometimes
2 Often
3 Most of the time
4 Always
  9. In the last 3 months, how often did you have hard or lumpy stools? 0 Never or rarely
1 Sometimes
2 Often
3 Most of the time
4 Always
10. In the last 3 months, how often did you have loose, mushy or watery stools? 0 Never or rarely
1 Sometimes
2 Often
3 Most of the time
4 AlwaysIBS and Gender Role
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Table 2. Baseline and Clinical Characteristics of the Irritable Bowel Syndrome Patients Regarding Different Sex Groups
Variable Total (N = 144)
Sex groups
P-value
Male (n = 44) Female (n = 100)
Age (mean ± SD, yr)  37.50 ± 11.50 37.91 ± 11.45  37.32 ± 11.57 0.778
BMI (mean ± SD, kg/m
2)  24.64 ± 11.64 26.59 ± 19.68  23.74 ± 4.61 0.195
Marital status (n [%])
a
    Married 107/141 (75.9)       30 (68.2)  77/97 (79.4) 0.150
    Single    34/141 (24.1)       14 (31.8)  20/97 (20.6)
Educational status (n [%])
b
    Illiterate     7/143 (4.9)         1 (2.3)    6/99 (6.1) 0.337
    Primary and/or secondary school   76/143 (53.1)       27 (61.4)  49/99 (49.5)
    College and/or university    60/143 (42)       16 (36.4)  44/99 (44.4)
Occupational status (n [%])
    Housewife          42 (29.2)         0       42 (42) ＜ 0.001
c
    Student          17 (11.8)         2 (4.5)       15 (15)
    Practitioner          80 (55.6)       38 (86.4)       42 (42)
    Workless            5 (3.5)         4 (9.1)         1 (1)
Smoking (n [%])          14 (10)         9 (20.9)         5 (5) 0.011
c
Symptoms (n [%])
    Reflux          49 (34.3)       13 (29.5)       36 (36) 0.428
    Nausea          57 (39.6)         8 (18.2)       49 (49) ＜ 0.001
c
    Vomiting          18 (12.5)         3 (6.8)       15 (15) 0.273
    Anorexia          63 (43.8)       18 (40.9)       45 (45) 0.649
    Weight loss          48 (33.3)       16 (36.4)       32 (32) 0.609
    Fatigue         108 (75)       33 (75)       75 (75) 1.000
    Heart burn          51 (35.7)       13 (29.5)       38 (38) 0.309
Type of IBS (n [%])
    IBS-C (constipation)          52 (36.1)       14 (31.8)       38 (38)
    IBS-D (diarrhea)           49 (34)       17 (38.6)       32 (32) 0.550
    IBS-U (undefined)            3 (2.1)         0         3 (3)
    IBS-M (mixed)           40 (27.8)        13 (29.6)       27 (27)
aMissing = 3 (female), 
bMissing = 1 (female), 
cStatistically significant difference.
IBS, irritable bowel syndrome.
on the definitions recommended by ROME III criteria.
1 More 
precisely, the definition used to describe nausea was termed as 
chronic idiopathic nausea in ROME III criteria as bothersome 
nausea, occurring at least several times per week in the last 3 
months which was not usually associated with vomiting in the ab-
sence of abnormalities at upper endoscopy or metabolic disease 
that explains the nausea.
1
All of the recorded variables were compared between the 2 
genders.
Statistical Methods
Data were expressed as mean ± standard deviation for con-
tinuous and frequency percentage for nominal and categorical 
variables. Independent Sample T-test was used to compare the 
mean of continuous variables between males and females includ-
ing baseline characteristics, the mean score for each of the 10 
questions and total IBS module score. The comparison of qual-
itative variables between groups (such as subtypes of IBS) was 
performed by means of Chi-square test. The differences were 
considered statistically significant if the P-value was less than 
0.05 (maximum type one error of 5%) and all of the analytical 
procedures were performed by SPSS software version 16 (SPSS 
Inc., Chicago, IL, USA).
Results
Baseline and Clinical Characteristics
A total number of 144 IBS patients were recruited in this 
prospective study. They were consisted of 44 (30.6%) males and Sanam Javid Anbardan, et al
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Figure 1. Distribution of different types of irritable bowel syndrome in
female and male patients. IBS, irritable bowel syndrome; IBS-U, 
unsubtyped IBS; IBS-C; constipation predominant IBS; IBS-D, 
diarrhea predominant IBS; IBS-M, mixed IBS.
Figure 2. Distribution of different severity of more frequent bowel 
movements after the start of discomfort or pain in female and male 
irritable bowel syndrome patients (P = 0.007).
Figure 3. Distribution of different severity of more frequent looser 
stools after the start of discomfort or pain in female and male irritable 
bowel syndrome patients (P = 0.002).
Figure 4. Distribution of the frequency of loose, mushy or watery stools
within last 3 months in female and male irritable bowel syndrome 
patients (P = 0.002).
100 (69.4%) females with the mean age of 37.50 ± 11.50 years. 
Baseline and clinical characteristics of the patients regarding their 
gender group are shown in Table 2. The mean age of the patients 
was not significantly different between males and females (37.91 
± 11.45 years vs 37.32 ± 11.57 years, P = 0.778). Among base-
line characteristics, occupational status and smoking prevalence 
were significantly different between 2 genders (＜ 0.001 and 
0.011, respectively). Moreover, the only differently observed 
symptom was nausea which was significantly more prevalent in 
females (18.2% vs 49.0%, P ＜ 0.001).
Irritable Bowel Syndrome Module
The most common types of IBS were IBS-C (36.1%) and 
IBS-D (34%) forms, respectively. As shown in Figure 1, the 
commonest subtype of IBS in male patients was IBS-D (38.6%); 
while, IBS-C was the most frequent type among females (38%). 
However, this difference was not statistically significant (P = 
0.550). As shown in Figures 2 and 3, after the start of discomfort 
or pain, male patients had more frequent bowel movement and 
more looer stool than female patients (P = 0.007 and 0.002, re-
spectively). In addition, Figure 4 showed that the frequency of 
loose, mushy or watery stools within the last 3 months was also 
significantly more common in males (2.11 ± 1.67 vs 1.37 ± 
1.50, P = 0.002).
Discussion
Gender differences can be defined as male-female differences IBS and Gender Role
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in the incidence, prevalence, mortality, burden of diseases, other 
adverse health conditions and the responses to those diseases and 
conditions.
19 In this study, we report that gender is important in 
IBS. Although the debated finding of more women with C-IBS 
was confirmed, more men than women appeared to have D-IBS, 
according to ROME III criteria. Even though the qualitative 
comparison of different subtypes of IBS between male and female 
failed to meet the statistically significant level with the sample size 
of 144, the answers to the corresponding questions of ROME III 
IBS module were significantly different between 2 genders sug-
gesting the higher prevalence of bowel movements and looser 
stool in males.
Gender differences in IBS are well established. In one of the 
pivotal studies in this area, Drossman et al
20 noted that the ratio of 
men:women with IBS was as high as 2:1, although other have re-
ported a somewhat lower ratio.
21,22 However, IBS is a heteroge-
neous disease, with some patients suffering more with con-
stipation symptoms and others with diarrhea. As a result of this 
heterogeneity, patients with IBS historically have been assigned 
to either one of the groups, IBS-C or IBS-D.
23 To define these 
categorical assignments better, Rome III criteria provided a con-
sensus-based approach in which gender was evaluated according 
to the presence or absence of IBS-C or IBS-D.
24 In 2 studies, the 
gender disparity in IBS appeared more prominent among pa-
tients who had IBS-C.
25,26 These studies suggest that the prepon-
derance of women with IBS is more pronounced in the IBS-C 
category and that, in fact, the IBS-C category may account for all 
the female gender inequalities in IBS.
In addition, there is a greater prevalence of IBS in patients 
with other chronic pain conditions, which are more common in 
women, such as chronic fatigue syndrome compared with the 
general population, and similarly there is a greater prevalence of 
these conditions in patients with IBS.
27
With regard to specific IBS symptoms, women with IBS are 
more likely to report problems with constipation while men more 
commonly report diarrhea. There have been some studies show-
ing that women report significantly more constipation as com-
pared to men.
28 Hyams et al
29 looked at symptoms of constipation 
and found that women were significantly more likely to report 
straining and bloating. Talley et al
21 found that significantly more 
women than men reported to experience bloating. In another 
study,
30 women were initially found to have significantly more 
constipation, but when the investigators controlled for factors 
such as laxative use and a feeling of incomplete evacuation, the 
significance disappeared. Hochstrasser and Angst
31 found that 
significantly more men than women reported constipation.
Two studies examining gender differences in diarrhea found 
opposite results, with Hochstrasser and Angst,
31 utilizing ROME 
criteria I, showing significantly more women than men having di-
arrhea, whereas Talley et al,
21 utilizing ROME criteria I, found 
that, in their sample, more men reported diarrhea. Findings re-
garding gender differences in overall symptomology compatible 
with an IBS diagnosis are similarly inconsistent, with several 
studies finding no gender differences,
21,29-31 whereas other stud-
ies
25,32 showed more women than men reporting symptoms that 
met the Manning criteria for the diagnosis of IBS. Most recently, 
published Herman et al
33 assessed the association of constipation 
and gender in IBS, and reported that the female:male ratio sig-
nificantly increased according to the severity of constipation rela-
tive to the severity of diarrhea.
Ali et al
34 looked into the relationship between gender role 
and illness behavior in IBS and found a correlation between what 
were typically viewed as feminine characteristics and disease con-
viction in both male and female IBS patients in a tertiary care 
setting. Specifically, women and men who showed high scores on 
traits such as nurturance also showed high scores on disease 
conviction. One important implication of this finding is that it 
may be the feminine gender role, rather than being female, that is 
influential in affecting patients’ attributions to their illness.
Another symptom which was found to have a gender-related 
preponderance in our IBS patients was nausea. Our results show 
that nausea has an approximately 2.5-fold higher prevalence in 
women with IBS compared with the men. Similar findings was 
reported from our previous investigation based on ROME II cri-
teria where nausea was shown to be more complained among fe-
male IBS sufferers (13.2% vs 26.7%, P = 0.020).
17 Admittedly, 
Lee et al
15 declared that female IBS patients more often reported 
nausea, alterations of taste and smell, and unpleasant sensations 
on the tongue. On the study of 714 ROME I positive IBS pa-
tients, nausea was twice as commonly reported by premenopausal 
women than by postmenopausal women, while, no differences 
were found between postmenopausal women and age-matched 
male IBS cases. Lee et al
15 suggested that this prominent preva-
lence of nausea in premenopausal women with IBS might be re-
lated to the menstrual cycle. Mayer et al
16 also believed that nau-
sea as well as stomach and pelvic cramping pains were rated high-
er during menstruation in the IBS female patients.
The question of the role of gender in IBS has risen from 
studies suggesting an effect of the menstrual cycle on symptom 
severity, as it appears to emerge around the time of puberty and Sanam Javid Anbardan, et al
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increases during the early adult years with the more recent drug 
studies suggesting that the 5-HT3 antagonist alosetron and the 
partial 5-HT4 agonist tegaserod are more effective in women 
than in men.
2
The variability in reproductive hormones across the menstru-
al cycle as well as the decrease in ovarian function at menopause 
may serve as important factors influencing GI motility and vis-
ceral sensitivity. Several studies have demonstrated the impact of 
menstrual cycle on GI symptoms.
35-37 Specifically, many women 
with and without IBS experience an increase in GI symptoms in-
cluding abdominal pain, bloating, and intestinal gas during the 
late luteal and menstruation phases of the cycle. In addition, men-
strual cycle phase may affect visceral sensitivity in women with 
IBS.
16
Although this study investigated the epidemiologic associa-
tion between IBS and gender, the exact role of gender remains to 
be determined. Continuing exploration of the epidemiology of 
IBS repeatedly suggests that, in addition to functional gastro-
intestinal disease in general, pain-related symptoms,
16 bloating 
and constipation are clearly more prevalent in females. Under-
standing the reasons for this disparity has been challenging, and a 
wide variety of biopsychosocial hypotheses have been explored. 
Comprehensive reviews of gender and IBS are widely available. 
Many independent factors that might potentially explain the gen-
der disparity have been evaluated such as the differences in the 
sex hormones.
38 Examination of abuse as a risk factor for IBS has 
not convincingly suggested gender disparity. No differences in 
health care-seeking behavior
23 or psychological distress
24 have 
been observed between male and female patients with IBS.
Generally, there are some evidences to be offered for gen-
der-related differences in IBS such as the symptom presentation 
and IBS subtypes, as well as pathophysiology and treatment 
responses.
39 These clues were further evaluated by our inves-
tigation which was shown some female prominence in the preva-
lence of nausea in IBS patients. Our study utilized the Rome III 
criteria for IBS assessment. Among the previous investigations 
on gender-related differences in IBS patients, few have examined 
this association according to the current ROME III criteria. 
Although the use of ROME III criteria and the appropriate sam-
ple size strengthen our findings, there are some limitations to the 
present study, too. The evaluations and comparisons in our study 
were based on the ROME criteria and modules and therefore, 
did not take the severity of constipation or diarrhea into account. 
However, there are not enough validated objective tools to meas-
ure the severity or degree of such symptoms. Another issue that 
could be problematic was the patient selection. Our study was a 
single center investigation which could be affected by the specific 
socio-cultural habits of the inhabitants in the region. Especially 
the gender issue may have had a considerable role in this case and 
therefore, it necessitates the performance of population- and mul-
ticenter-based studies.
In conclusion, nausea was found to be reported more by fe-
male IBS patients. Although qualitative comparison of different 
subtypes of IBS between two genders failed to meet the statisti-
cally significant level, the answers to the corresponding questions 
of ROME III IBS module were significantly different between 
two genders suggesting the higher prevalence of bowel move-
ments and looser stool in males. Our findings indicate the gen-
der-related differences in IBS which necessitates more inves-
tigations on the underlying reasons of these disparities.
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